Boston Scientific Corp (BSX)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$92.00

Buy

$92.97

arrow-up$0.83 (+0.90%)

Prices updated at 13 Dec 2025, 00:56 EST

Prices minimum 15 mins delay

Prices in USD

Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Mr. Michael F. Mahoney

CEO

Mr. Michael F. Mahoney

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

53,000

Head office

300 Boston Scientific Way

Marlborough

United States

01752-1234

+1 508 683-4000

BSXInvestorRelations@bsci.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Senator John E. Sununu Independent Director	0.14m
Mr. Jonathan R. Monson Executive Vice President and Chief Financial Officer	-
Mr. David C. Habiger Independent Director	-
Mr. Edward J. Ludwig Lead Independent Director	0.16m
Mr. David S. Wichmann Independent Director	0.15m
Ms. Ellen M. Zane Independent Director	0.14m
Mr. Yoshiaki Fujimori Independent Director	0.14m
Mr. Joseph M. Fitzgerald Executive Vice President and Group President, Cardiology	0.84m
Mr. Michael F. Mahoney Chairman of the Board, President and Chief Executive Officer	1.40m
Mr. Vance R. Brown Senior Vice President, General Counsel, Corporate Secretary	-
Dr. Cheryl B. Pegus, M.D. Independent Director	0.08m
Mr. John Bradley Sorenson Executive Vice President, Global Operations	-
Mr. Arthur C. Butcher Executive Vice President and Group President, MedSurg and Asia Pacific	0.71m
Dr. Jessica L. Mega, M.D.,M.P.H. Independent Director	0.12m
Ms. Susan E. Morano Independent Director	0.12m
Ms. Miriam O’Sullivan Senior Vice President and Chief Human Resources Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
BlackRock Inc	145,175,869
Vanguard Group Inc	137,134,110
FMR Inc	99,477,701
Fidelity Management and Research Company	99,477,701
Fidelity Management & Research Company LLC	79,775,554

Director dealings

Date chevron-l-regular chevron-r-regular	Action
03 Dec 2024	-
11 Feb 2025	-
11 Feb 2025	-
10 Dec 2024	-
02 Dec 2024	-
02 Dec 2024	-
02 Dec 2024	-
02 Dec 2024	-
02 Dec 2024	-
27 Nov 2024	-
26 Nov 2024	-
26 Nov 2024	-
25 Nov 2024	-
25 Nov 2024	-
25 Nov 2024	-
25 Nov 2024	-
25 Nov 2024	-
25 Nov 2024	-
21 Nov 2024	-
12 Nov 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.